Inner Mongolia Furui Medical Science Co., Ltd. (SHE:300049)

SHE:300049 Ratios and Metrics

Market cap in millions CNY. Fiscal year is January - December.

Fiscal Year	Current	FY 2024	FY 2023	FY 2022	FY 2021	FY 2020
Period Ending	Sep 26, 2025	Dec 31, 2024	Dec 31, 2023	Jan 1, 2023	Jan 1, 2022	Dec 31, 2020
Market Capitalization	20,032	8,401	11,466	6,426	3,768	2,092
Market Cap Growth	92.93%	-26.73%	78.43%	70.55%	80.15%	7.37%
Enterprise Value	19,813	8,244	11,224	6,210	3,561	1,937
Last Close Price	75.60	31.54	43.59	24.24	14.58	8.10
PE Ratio	222.56	74.16	112.90	65.65	39.47	33.79
Forward PE	104.28	29.24	29.24	29.24	29.24	29.24
PS Ratio	14.11	6.23	9.94	6.37	4.19	2.59
PB Ratio	8.93	3.95	6.21	3.52	2.09	1.30
P/TBV Ratio	19.38	8.53	11.83	6.48	3.90	2.67
P/FCF Ratio	2006.74	3440.21	99.14	65.12	26.36	23.14
P/OCF Ratio	79.75	37.94	37.61	33.92	16.93	10.45
PEG Ratio	-	1.62	1.62	1.62	1.62	1.62
EV/Sales Ratio	13.95	6.11	9.73	6.16	3.96	2.40
EV/EBITDA Ratio	51.82	22.97	36.50	26.27	16.10	9.23
EV/EBIT Ratio	69.14	28.76	46.70	34.81	21.27	13.80
EV/FCF Ratio	1984.80	3376.06	97.05	62.93	24.91	21.42
Debt / Equity Ratio	0.04	0.04	0.03	0.03	0.06	0.08
Debt / EBITDA Ratio	0.20	0.20	0.18	0.22	0.46	0.61
Debt / FCF Ratio	7.84	31.29	0.51	0.56	0.76	1.41
Asset Turnover	0.48	0.47	0.45	0.40	0.37	0.36
Inventory Turnover	2.72	2.91	2.95	2.71	2.33	2.06
Quick Ratio	3.60	3.56	3.66	4.63	3.67	3.56
Current Ratio	4.20	4.12	4.21	5.20	4.18	4.20
Return on Equity (ROE)	7.79%	9.86%	9.64%	8.01%	8.65%	5.70%
Return on Assets (ROA)	6.06%	6.28%	5.81%	4.42%	4.35%	3.86%
Return on Capital (ROIC)	8.31%	8.72%	7.93%	5.88%	5.72%	5.14%
Return on Capital Employed (ROCE)	10.30%	10.70%	10.20%	7.80%	7.40%	6.80%
Earnings Yield	0.45%	1.35%	0.89%	1.52%	2.53%	2.96%
FCF Yield	0.05%	0.03%	1.01%	1.54%	3.79%	4.32%
Dividend Yield	-	-	-	0.83%	-	-
Payout Ratio	2.32%	1.94%	52.60%	72.95%	2.04%	6.07%
Buyback Yield / Dilution	-0.56%	-0.50%	0.01%	-1.30%	-1.31%	-0.03%
Total Shareholder Return	-	-0.50%	0.01%	-0.47%	-1.31%	-0.03%

Source: S&P Global Market Intelligence. Standard template. Financial Sources.